Solid Biosciences Stock Jumps 11% Post-market on FDA Update

Seeking AlphaJan 8 06:23

RBC Capital Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Cuts Target Price to $58

Futu NewsJan 7 22:31 · Ratings

RBC Cuts Price Target on PTC Therapeutics to $58 From $63, Keeps Outperform Rating

MT NewswiresJan 7 20:19 · Ratings

Insiders At PTC Therapeutics Sold US$1.2m In Stock, Alluding To Potential Weakness

Simply Wall StJan 3 02:36

PTC Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR NewswireDec 23, 2024 21:00

J.P. Morgan's Top Healthcare Stocks for 2025

Seeking AlphaDec 21, 2024 00:30